. Transcriptional Activation of Chromatin-Assembled ␤-Globin Template Requires Both EKLF and a Coactivator, E-RC1 (A) Transcription of chromatin-reconstituted ␤-globin template. Glycerol gradient fraction or DNA-cellulose fraction containing the EKLF coactivator E-RC1 and recombinant purified EKLF protein were added to 1 g chromatin as indicated. Relative fold activation is shown below each lane. Quantitation was performed using a Molecular Dynamics phosphorimager. Fold transcription activation was determined by subtracting a background value for each lane from both ␤-globin and AdLuc signals. The control AdLuc signal for lane 2 was set at one and the relative AdLuc values were divided into the appropriate ␤-globin signal. Repressed ␤-globin transcription (lane 2) was then set at one. Primer extension products are marked by arrows. M, MspI-digested pBR322 as a molecular weight marker. (B) EKLF and the coactivator E-RC1 have no effect on transcription of free DNA. ␤-globin template (250 ng) was incubated with 2.5 l DNA-cellulose fraction containing E-RC1 and/or 9.3 pmol EKLF, as indicated, and transcribed as described for the chromatin templates in Experimental Procedures. Relative fold transcriptional activation is shown under each lane. M, MspI-digested pBR322 as a molecular weight marker. (C) Experimental flowchart. See Experimental Procedures for detailed protocols. 1993). EKLF was the founding member of the Krü ppelusing an in vitro chromatin assembly system. We show that EKLF requires a coactivator to form a transcriptionlike factor family, named as such because the zinc fingers possess a high degree of similarity to the Drosophally competent ␤-globin promoter by structurally remodeling repressed chromatin in an ATP-dependent manila gap gene Krü ppel. Other members of this new family include LKLF (lung Krü ppel-like factor), found predominer. We identify the coactivator E-RC1 as a member of the mammalian SWI/SNF family of chromatin remodelnantly in lung and spleen (Anderson et al., 1995) ; BKLF (basic Krü ppel-like factor), highly expressed in the mouse ing complexes. Although E-RC1 has general chromatin disruption activity, it is unable to activate transcripembryonic midbrain (Crossley et al., 1996) ; and GKLF (gut-enriched Krü ppel-like factor), an epithelial-specific tion in combination with another DNA-binding protein, TFE-3, on the chromatin-assembled human immunodefactor associated with growth arrest (Shields et al., 1996) . EKLF regulates the human ␤-globin promoter ficiency virus-1 (HIV-1) promoter. Thus, E-RC1 displays selectivity toward EKLF and demonstrates potential through the Ϫ90 CACCC sequence. Naturally occurring mutations within this CACCC box result in ␤-thalessefunctional diversity among members of the mammalian SWI/SNF family. mias in humans (Orkin et al., 1982; Kulozik et al., 1991) , caused by reduced levels of ␤-globin expression due to decreased DNA binding and transcriptional activation Results by EKLF (Feng et al., 1994) . Thus, EKLF is unquestionably critical for stage-specific expression of the ␤-globin
Transcription from the Chromatin-Reconstituted Human ␤-Globin Promoter Depends upon gene (Donze et al., 1995) .
To understand the mechanism of action of this key EKLF and a Coactivator, E-RC1 Plasmids containing the intact ␤-globin promoter from erythroid regulator, we have reproduced EKLF-mediated transcriptional activation of the ␤-globin promoter Ϫ385 to ϩ18, linked to the CAT gene, were assembled (A) Hypersensitive site formation occurs only in the presence of both EKLF and E-RC1. After assembly, chromatin was incubated with DNA-cellulose E-RC1 fraction and/or EKLF as indicated. The chromatin reactions were then split, and one-half was transcribed as a control (data not shown). Remaining chromatin was divided into three tubes (100 ng chromatin per tube) and digested with DNase I for 1 min at 27Њ C. Triangles indicate increasing amounts of DNase I. Free DNA was digested with 0, 0.0015, 0.0045, or 0.0135 U DNase I (3.1 U/g). Chromatin reactions were digested with 0, 0.3, 0.9, or 2.7 U DNase I. Following purification, DNA was digested with NcoI. The indirect end-labeling procedure is described in Experimental Procedures. Brackets indicate the promoter region from Ϫ120 to ϩ10. M, ␤-globin plasmid digestions used as molecular weight markers. Bands represent digests of NcoI (4.7 kb), NcoI/BsaAI (841 bp), and NcoI/EcoRI (301 bp).
(B) The DNase I hypersensitive site is abolished in the presence of apyrase. After assembly, 1 g chromatin was incubated with either buffer or 0.2 U apyrase as indicated at 27ЊC for 10 min. Reactions were then incubated with DNA-cellulose E-RC1 fraction and/or EKLF as indicated. Chromatin was divided into six tubes with 150 ng chromatin per tube and digested with 0, 0.9, 1.2, 1.5, 1.8, or 2.1 U DNase I. Triangles indicate increasing amounts of enzyme. Brackets show Ϫ120 to ϩ10 of the promoter region. M, molecular weight markers as described in Figure  legend 2A.
into chromatin using Drosophila embryonic extracts The reconstituted chromatin templates used in these experiments contain evenly spaced nucleosomes, as (Bulger and Kadonaga, 1994) . As expected, chromatinassembled templates are transcriptionally repressed determined by micrococcal nuclease analysis, and the bulk chromatin structure is unaffected by the addition ( Figure 1A , lane 2). We initially examined whether binding of the erythroid-specific transcriptional activator EKLF of EKLF and E-RC1 (data not shown). EKLF and E-RC1 are added after nucleosome assembly is complete (as to the Ϫ90 CACCC box in the human ␤-globin promoter could generate an open chromatin structure and allow diagrammed in Figure 1C ), suggesting that an active chromatin remodeling process is occurring. Moreover, transcription to occur. These experiments indicated that EKLF alone could not efficiently activate ␤-globin ex-EKLF and E-RC1 are unable to stimulate transcription of free DNA ( Figure 1B ), indicating that they function pression (lane 5), which led us to search for a possible coactivator of EKLF function. Chromatographic fractionspecifically through chromatin structure. ation of protein extracts from mouse erythroleukemia (MEL) cells, which represent the definitive erythroid linChromatin Structural Remodeling of the ␤-Globin Promoter Requires Both EKLF and E-RC1 eage and express high levels of endogenous ␤-globin genes, resulted in the purification of an activity, EKLF To examine the nucleosomal structure of in vitro-assembled ␤-globin promoters, indirect end-labeling analysis coactivator-remodeling complex 1 (please see Figure  4C for an SDS-PAGE analysis of purified E-RC1). This of DNase I digested chromatin was performed. Importantly, these digestions were carried out prior to trancomplex functioned with EKLF to activate chromatinassembled ␤-globin promoters (lanes 4 and 6), yet was scription and thus reflect potentially active, rather than transcribing, promoters. A DNase I hypersensitive reinsufficient by itself (lanes 3 and 7) . Additionally, neither EKLF nor E-RC1 could individually activate transcription gion from approximately Ϫ120 to ϩ10 in the ␤-globin promoter was observed in the presence of both EKLF when bound to the DNA template prior to chromatin formation (data not shown).
and E-RC1 (Figure 2A, lane 15) . This pattern resembles Transcriptional activation of chromatin-reconstituted HIV-1 template. The plasmid template was assembled into chromatin in the presence (lanes 3-8) or absence (lanes 1, 2, 9-16) of purified TFE-3. Following assembly, the DNA-cellulose fraction of E-RC1 (2.5 l, lanes 5 and 6 and 9 and 10; or 5 l, lanes 7 and 8, 11 and 12, 15 and 16) and TFE-3 (lanes 13-16) were added to 100 ng of HIV-1 template and incubated for 10 min at room temperature. Transcription proceeded following the addition of a nuclear HeLa extract and incubation at 30ЊC for 30 min. Primer extension products of the HIV-1 promoter and the ␣-globin internal control are indicated by arrows.
the hypersensitive structure of the active ␤-globin pro-
The EKLF Coactivator E-RC1 Is Identified as a Member of the Mammalian SWI/SNF Family of Chromatin moter in vivo which maps from 100-150 bp 5Ј of the cap site (Groudine et al., 1983) . Neither EKLF (lanes Remodeling Complexes E-RC1 was purified according to the scheme shown in 17-19) nor E-RC1 (lanes 10-12) were sufficient alone to generate an open chromatin configuration. Since most Figure 4A . By glycerol gradient sedimentation, E-RC1 was identified as a large 18.7S multiprotein complex chromatin remodeling events are energy-dependent, we asked whether hypersensitive site formation in the that cofractionates with known mammalian SWI/SNF subunits. When fractions across the 20%-35% glycerol ␤-globin promoter was dependent on ATP. Chromatin templates were incubated with the ATP-hydrolyzing regradient were assayed, transcriptional activity peaked in fractions 4 and 5 ( Figure 4B , lanes 7 and 8), as did agent apyrase prior to addition of EKLF and E-RC1. Indeed, formation of the open ␤-globin promoter strucDNase I hypersensitive site formation (data not shown).
An SDS-PAGE analysis shows the purity and protein ture by these proteins requires ATP ( Figure 2B , compare subunit composition of these fractions ( Figure 4C ). lanes 8-12 to 14-18).
Western blot analyses using antibodies to mammalian SWI/SNF subunits were conducted on the same glycerol E-RC1 Displays Functional Selectivity for EKLF gradient fractions ( Figure 4D ). The subunits BAF155, To analyze the specificity of E-RC1 as a coactivator BAF57, and BRG1 all comigrate with the transcriptional of EKLF, we examined whether it could function with activity in fractions 4 and 5. Moreover, BAF170 and INI1 another protein, TFE-3, to facilitate transcription from (BAF47) proteins also peak in these fractions (data not the HIV-1 promoter. TFE-3 is a member of the helixshown). Interestingly, BRG1 protein is found in a second loop-helix family of DNA-binding proteins and interacts peak (fractions 7 and 8) that does not support ␤-globin with an E box motif at Ϫ177 within the HIV-1 enhancer.
transcription, suggesting that other BRG1-containing Recombinant TFE-3 and other HIV-1 enhancer-binding complexes with different functions may exist. E-RC1 proteins have been shown to activate efficiently trancofractionated with the core SWI/SNF subunits BAF57, scription of a chromatin-assembled HIV-1 template in BAF155, and BRG1 through each of the three column vitro (Sheridan et al., 1995) . As shown in Figure 3 , presteps (data not shown) and may represent a major SWI/ binding of TFE-3 alone to HIV-1 DNA followed by chro-SNF activity in MEL cells. A small amount of RNA polymatin assembly with Drosophila embryo extracts genermerase II was present in the DNA-cellulose fraction, as ates a structure that is active for transcription in vitro detected by Western blot analysis using an antibody to (lanes 3 and 4) relative to chromatin-repressed temthe CTD. However, after the glycerol gradient step, RNA plates lacking prebound TFE-3 (lanes 1 and 2). Addition polymerase II was only detectable in fraction 8 and, of E-RC1 to TFE-3-bound HIV-1 chromatin failed to thus, did not comigrate with the EKLF-dependent E-RC1 appreciably increase transcription (lanes 5-8). When coactivator (data not shown). All antibodies to mamma-E-RC1 was analyzed for its ability to facilitate TFE-3 bindlian SWI/SNF subunits tested so far have comigrated ing to assembled chromatin (postbinding), as ␤-globin with this transcriptional activity. Although E-RC1 was activation by EKLF is normally assayed, no transcription originally purified from erythroid cells, it may not be occurred with (lanes 15 and 16) or without E-RC1 (lanes tissue-restricted. A partially purified E-RC1 fraction from 13 and 14). Thus, E-RC1 displays functional selectivity HeLa cells also displays EKLF coactivator activity. for EKLF, as it is not a coactivator of TFE-3. These results
To determine whether purified E-RC1 displays classiindicate that E-RC1 does not function generally to facilical chromatin remodeling activity, a mononucleosomal tate the interaction of DNA-binding proteins with chroDNase I footprinting assay was performed ( Figure 5A ). matin templates to enable transcriptional activation. In-A rotationally positioned nucleosome was assembled stead, E-RC1 shows selectivity in the factors and genes by salt dialysis onto a DNA fragment containing a single that it regulates. Although it is unlikely that E-RC1 is a copy of the sea urchin 5S nucleosome-positioning secoactivator only of EKLF, the data suggest that its funcquence. When this positioned nucleosome was digested tion may be restricted to a specific class of transcripwith DNase I, a 10 bp repeat ladder was produced (lane 3). In the presence of ATP, E-RC1 was able to remodel tional activators. (B) Transcriptional activation of chromatin reconstituted ␤-globin template with EKLF and glycerol gradient fractions of E-RC1. A 13 ml gradient was divided into 11 fractions from 1 (bottom) to 11 (top). Fifty microliters of each fraction and EKLF protein was added to 1 g chromatin. Reactions were then split, and half was DNase I digested and analyzed for hypersensitivity by indirect end-labeling analysis (data not shown). The remaining chromatin was transcribed. M, MspI-digested pBR322 as a molecular weight marker. Relative fold transcriptional activation is given under each lane. (C) SDS-PAGE analysis of E-RC1 glycerol gradient fractions. Ten microliters of each fraction was analyzed by 7.5% SDS-PAGE and visualized by silver staining. S, DNA-cellulose fraction that was the starting material for glycerol gradients. M, 10 kDa molecular weight markers (GIBCO). Sedimentation values for standards are shown: thyroglobulin (19.2S), apoferritin (17.6S), ␤-amylase (11.2S), and bovine serum albumin (4.6S). The S value for the active complex was calculated from three separate glycerol gradients; the average was 18.7S. (D) Western blot analysis of glycerol gradient fractions reveals that E-RC1-mediated transcriptional activity comigrates with SWI/SNF subunits. Ten microliters of each glycerol gradient fraction was electrophoresed on a 7.5% SDS-PAGE and the subunit composition determined by Western blot analysis. S, 90 mM DNA-cellulose fraction that was the starting material for the gradient. M, ECL markers, sizes indicated. and disrupt the nucleosome to produce a DNase I digesa key SWI/SNF subunit of E-RC1 plays a functional role in EKLF-dependent ␤-globin transcription. tion pattern intermediate between that of a nucleosome and free DNA (lanes 7 and 8). In the absence of ATP, no
Immunoprecipitations from E-RC1 chromatographic fractions using antibodies to BAF155 and BAF57 were nucleosome disruption by E-RC1 was observed (lanes 4 and 5). This DNase I pattern is consistent with that carried out to further confirm that E-RC1 is a member of the mammalian SWI/SNF family. SWI/SNF complexes generated by other SWI/SNF-related complexes purified from both yeast (Cô té et al., 1994) and HeLa cells cannot be eluted intact from antibody beads, but they have been shown to retain activity while on the beads .
To confirm the role of one of the SWI/SNF subunits after thorough washing. For example, mammalian SWI/ SNF complexes on beads are able to disrupt monoin transcription, immunoneutralizations with an antibody to the HMG domain-containing BAF57 SWI/SNF subunit nucleosomes and facilitate factor binding (Wang et al., 1996a) . As shown in Figure 5C , both BAF57 and BAF155 were conducted. As shown in Figure 5B , anti-BAF57 antibody specifically interfered with transcriptional actiimmunoprecipitates were active for DNase I hypersensitive site formation in the presence of EKLF (lanes 5 vation, neutralizing 73% of ␤-globin promoter activity but not that of a control template (AdLuc) (compare and 17, respectively). A mock immunoprecipitate shows limited activity (lane 7). From this data, we conclude that lanes 3 and 4). As controls, preimmune sera and antiRsc6 had no effect (compare lane 4 with 5 and 6). Thus, mammalian SWI/SNF immunoprecipitates from E-RC1 fractions are able to function with the erythroid protein SWI/SNF (BAF) group of chromatin remodeling complexes could replace E-RC1, we obtained SWI/SNF puri-EKLF to alter the chromatin structure of the ␤-globin fied from Jurkat T cells, expressing an HA-tagged BAF57 promoter. Thus, E-RC1 is a true member of the mammapolypeptide (Wang et al., 1998) . The activity of this comlian SWI/SNF group. plex was measured by a DNase I footprinting analysis By Western blot analysis, we were able to compare of a positioned mononucleosome, as in Figure 5A . This BAF57 levels in E-RC1 preparations to a titration of bacparticular SWI/SNF complex cannot substitute for E-RC1 terially expressed BAF57 of a known concentration (data in either EKLF-dependent ␤-globin transcriptional actinot shown). One subunit of BAF57 is present in SWI/ vation or in DNase I hypersensitive site formation in the SNF purified from Jurkat T cells that express an HA-␤-globin promoter when used at ratios of up to 1 comtagged BAF57 (Wang et al., 1998) . For the purpose of plex per 40 nucleosomes (data not shown). When E-RC1 these calculations, we are assuming the same is true of and T cell-derived SWI/SNF are compared on an SDS-E-RC1. When the DNA-cellulose fraction is used as a PAGE, their subunit compositions appear almost identisource of E-RC1, one complex is present for every temcal, with some differences in minor bands ( Figure 6 ). plate-or, approximately, 1 E-RC1 per 27 nucleosomes.
With the exception of the few nonspecific bands in the Glycerol gradient-purified E-RC1 is used at a ratio of 1 Jurkat SWI/SNF preparation (see Figure 5a ; Wang et al., complex for every 49 nucleosomes, with comparable 1998), all of the major mammalian SWI/SNF subunits results for both transcription ( Figure 1A ) and hypersensicomigrate with the major polypeptides in purified E-RC1. tive site formation (data not shown).
Although E-RC1 and the T cell-derived SWI/SNF appear to be functionally distinct, it is important to note that To determine whether or not other members of the Southwood, 1995) . Two deletion mutants, ⌬20-60 and ⌬60-196, that remove portions of this core domain are unable to activate transcription in either transient transfections (Chen and Bieker, 1996) or in our in vitro system ( Figure 8A , compare lane 3 with 4 and 5). Both protein mutants are able to bind DNA with equal or greater efficiency than wild-type protein in a DNase I footprinting analysis of free DNA ( Figure 8B) . Thus, our E-RC1-dependent in vitro chromatin transcription assay reflects genuine transactivation by EKLF.
Although the activation domain of EKLF is required for transcription of a chromatin-assembled template ( Figure 8A) , it is not needed to generate an open promoter conformation. As shown in Figure 8C , both protein deletion mutants are capable of forming a DNase I hypersensitive region (lanes 7-12) that is indistinguishable from that generated by wild-type protein (lanes 4-6). As observed with intact EKLF, the deletion mutants are dependent upon the presence of E-RC1 for hypersensitive site formation, as they cannot function alone (data not shown). Thus, the activation domain of EKLF must function at a step subsequent to the generation of an chromatin conformation that is shown by a reduction in DNase I hypersensitivity ( Figure 8C, lanes 16-18) . From these data, we conclude that EKLF binding, in combinaother SWI/SNF family members may share the same tion with E-RC1, is necessary for an open chromatin characteristics as E-RC1, and the ability to activate tranconfiguration within the ␤-globin promoter. scription by EKLF may be a general property of SWI/ SNF complexes.
Discussion E-RC1-Dependent ␤-Globin Promoter Activation Requires an Intact Ϫ90 EKLF-Binding
We have reproduced stage-specific activation of a chroSite and EKLF Activation Domain matin-assembled human ␤-globin promoter in vitro. We Many ␤-thalessemias are caused by mutations within find that chromatin remodeling and transcriptional activthe ␤-globin locus. One such point mutation occurs ity are dependent upon both the erythroid Krü ppel-like within the Ϫ90 EKLF-binding site of the ␤-globin profactor (EKLF) and a SWI/SNF complex, E-RC1. This demmoter at Ϫ87 (C to G) (Orkin et al., 1982) , which efonstrates that a member of the mammalian SWI/SNF fectively eliminates EKLF binding and transactivation (BAF) family of complexes can regulate transcription of (Feng et al., 1994) . The reduction of ␤-globin expression a chromatin template in vitro. Furthermore, our analyses seen in ␤-thalessemia patients has been reproduced in provide insight into the specific mechanisms by which our in vitro system using chromatin-reconstituted temthe critical erythroid factor EKLF functions within chroplates. As shown in Figure 7A , the chromatin-assembled matin. mutant ␤-globin promoter is not competent for transcriptional activation by EKLF and E-RC1 (compare lanes 5 and 6 with 13 and 14). However, both wild-type and Possible Mechanism of Action of SWI/SNF-Related E-RC1 mutant promoters transcribe with equal efficiency as free DNA ( Figure 7B) . A DNase I footprint analysis conOur studies reveal that EKLF is dependent upon E-RC1 for the formation of an open, poised promoter. Several firms that EKLF is unable to bind the mutant site ( Figure  7C , compare lanes 2 and 3 with 5 and 6). Therefore, potential mechanisms of action exist. EKLF may first bind its site within the promoter and identify nearby EKLF must bind to its site at Ϫ90 to function as an activator of a chromatin-assembled promoter, and its nucleosomes as a target for E-RC1 activity. Yeast SWI/ SNF has been shown to act transiently to disrupt a regulatory effects are more pronounced in a chromatin environment than as free DNA.
nucleosome marked by GAL4-AH binding (Owen-Hughes et al., 1996) . E-RC1 may also function to promote EKLF (A) Transcription of chromatin-assembled ␤-globin templates. One microgram template, containing either wild-type or mutant promoter, was incubated with E-RC1 (DEAE fraction) and/or EKLF protein as indicated. In this case, E-RC1 and EKLF protein were incubated with the template throughout chromatin assembly; the results are not affected as a result of the change in the time of factor addition. The sequence of the wild-type and mutant EKLF sites are shown.
(B) The EKLF mutant ␤-thalessemia promoter is readily transcribed as free DNA. One microgram template was carried through a mock chromatin-assembly protocol, with buffers substituting for the chromatin-assembly extract and histones. M, MspI-digested pBR322 as a molecular weight marker. (C) DNase I footprint analysis of wild type and mutant ␤-globin promoters. DNA fragments spanning Ϫ170 to Ϫ3, from either the wild-type or Ϫ87 point mutant promoter, were generated by PCR and footprinted with 7.5 pmol or 15 pmol EKLF as indicated by triangles. The EKLF DNA-binding site is marked by brackets.
al., 1994), TATA-binding protein (TBP) (Imbalzano et al., even when prebound to the template (data not shown), suggesting that E-RC1 is functioning at a step subse-1994), Sp1, USF, and NF-KB (Utley et al., 1997) .
Studies both in vitro and in vivo suggest that SWI/ quent to factor binding. Further studies are necessary to address whether or SNF functions to assist transcription factors that have difficulty accessing their binding sites. In vitro, multimernot EKLF directly interacts with E-RC1 to recruit the complex to the ␤-globin promoter. A preliminary analysis ized factor binding sites enhanced nucleosomal interaction by a transcriptional activator and lowered the stimuof EKLF deletion mutants indicates that the C-terminal zinc fingers are a potential site for interaction (data not latory effect of SWI/SNF (Utley et al., 1997) . In vivo, GAL4 is dependent upon SWI/SNF to function at low-, but not shown). SWI/SNF increases transcriptional activation by the glucocorticoid receptor and the estrogen receptor high-, affinity GAL4 sites (Burns and . In the case of the human ␤-globin promoter, the initial when assayed in yeast, and SWI3 is coimmunoprecipiDNase I resistant structure indicated that a majority of tated with a 150-amino-acid fragment centered on the templates are likely to have a nucleosome located at zinc finger region of the glucocorticoid receptor (Yoshithe Ϫ90 EKLF site. E-RC1 may enhance EKLF binding naga et al., 1992) . to its nucleosomal site in addition to promoting nucleosome perturbation. Many transcription factors can be Transcriptional Activation of the ␤-Globin Promoter prebound to templates prior to chromatin formation. In
Once the promoter resides in an open chromatin configthis way, they presumably bypass the requirement of uration, transcriptional activation can occur. Although any complexes that would facilitate their binding to a the EKLF activation domain does not play a role in hypernucleosomal site. However, EKLF cannot activate transcription or remodel chromatin in the absence of E-RC1 sensitive site formation, it is critical at this stage. Our (B) DNA footprint of ␤-globin promoter with EKLF mutants lacking the activation domain. PCR-generated fragment from Ϫ170 to Ϫ3 of the ␤-globin promoter was incubated with 3 pmol protein or 7.5 pmol protein as indicated by triangles. The EKLF site is shown by brackets. (C) DNase I hypersensitive site formation within the ␤-globin promoter is dependent on an intact Ϫ90 CACCC element and is independent of an EKLF activation domain. Indirect end-labeling of DNase I digested chromatin. Chromatin templates containing either the wild-type promoter (lanes 1-12) or the Ϫ87 point mutant (lanes 13-21) were incubated with DNA-cellulose E-RC1 fraction and wild-type or mutant EKLF protein as shown. Reactions were then split, and half was transcribed as a control (data not shown). The remaining chromatin was divided into three tubes with 150 ng chromatin per tube and digested with 1.5, 2, or 3 U of DNase I. Triangles indicate increasing amounts of DNase I. Brackets show the Ϫ120 to ϩ10 region of the promoter. M, digested ␤-globin plasmid as a size marker.
results are in agreement with previous studies that indiImplications for ␤-Globin Gene Locus Regulation The ␤-globin locus is an ideal model system for the cated that the proline-rich activation domain is required for erythroid cell-specific activation of the ␤-globin gene exploration of the interdependence of tissue-and stagespecific expression with precise chromatin structures. (Bieker and Southwood, 1995) . The proline-rich domain of the transcriptional activator CTF1 has been shown to Our identification of an EKLF coactivator as a member of the SWI/SNF (BAF) family of chromatin remodeling bind TFIIB and facilitate its recruitment to a TBP-DNA complex (Kim and Roeder, 1994) . Likewise, the activacomplexes provides further evidence for that relationship. In addition to its role in the ␤-globin promoter, tion domain of EKLF may target a component of the RNA polymerase II machinery. Our findings are consis-EKLF is necessary for the formation of hypersensitive site 3 (HS3) within the locus control region (LCR) (Wijtent with studies of GAL4-VP16 (Pazin et al., 1994) and the thyroid hormone receptor (Wong et al., 1997 (Wong et al., ) that gerde, et al. 1996 . Further efforts are underway to elucidate the role of E-RC1 in EKLF-mediated chromatin remaintained that disruption of the chromatin structure of a promoter may occur in the absence of an activation modeling of the LCR and LCR promoter communication within the ␤-globin gene locus. domain but is not, in itself, sufficient to allow transcription. Gene activation in the context of chromatin has recently been reviewed (Armstrong and Emerson, 1998;  Experimental Procedures Cairns, 1998; Kadonaga, 1998) .
Plasmid Constructions
␤CAT plasmid was constructed as described (Jane et al., 1992) . Full-length EKLF was cloned into the NdeI and BamHI sites of the
Functional Selectivity of Chromatin
pET-14b bacterial expression vector (Novagen). EKLF⌬20-60 was Remodeling Complexes generated after ApaI restriction to remove the amino terminus.
A fascinating issue that will no doubt be the focus of (Wang et al., 1996a (Wang et al., , 1996b ). E-RC1 shows selectivity were purified under denaturing conditions on Ni 2ϩ -NTA resin (Qiaby facilitating EKLF-dependent ␤-globin transcription gen) and then renatured by step dialysis.
MEL (mouse erythroleukemia) cells were grown and the protein but not TFE-3-dependent HIV-1 expression, even though extracts prepared as previously described (Armstrong and Emerson, it remodels nucleosomes nonspecifically ( Figure 5A ).
